AA
IMCR icon

ALPS Advisors’s Immunocore IMCR Stock Holding History

ALPS Advisors’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.63M Buy
51,420
+10,159
+25% +$301K 0.01% 583
2026
Q1 		$1.24M Sell
41,261
-226
-0.5% -$7.31K 0.01% 539
2025
Q4 		$1.44M Buy
41,487
+17,148
+70% +$605K 0.01% 464
2025
Q3 		$884K Sell
24,339
-2,737
-10% -$93K ﹤0.01% 564
2025
Q2 		$850K Sell
27,076
-8,760
-24% -$272K ﹤0.01% 547
2025
Q1 		$1.06M Sell
35,836
-4,618
-11% -$139K 0.01% 465
2024
Q4 		$1.19M Buy
40,454
+2,104
+5% +$66.5K 0.01% 445
2024
Q3 		$1.19M Buy
38,350
+290
+0.8% +$10.5K 0.01% 458
2024
Q2 		$1.29M Buy
38,060
+2,925
+8% +$149K 0.01% 410
2024
Q1 		$2.28M Buy
35,135
+1,745
+5% +$120K 0.02% 330
2023
Q4 		$2.28M Sell
33,390
-2,778
-8% -$144K 0.02% 316
2023
Q3 		$1.88M Sell
36,168
-987
-3% -$58.4K 0.02% 336
2023
Q2 		$2.23M Buy
37,155
+5,476
+17% +$313K 0.02% 290
2023
Q1 		$1.57M Buy
31,679
+984
+3% +$55.3K 0.01% 347
2022
Q4 		$1.75M Buy
30,695
+6,737
+28% +$379K 0.02% 321
2022
Q3 		$1.13M Sell
23,958
-1,568
-6% -$74.7K 0.01% 437
2022
Q2 		$952K Sell
25,526
-18,700
-42% -$607K 0.01% 488
2022
Q1 		$1.32M Sell
44,226
-6,444
-13% -$163K 0.01% 282
2021
Q4 		$1.74M Sell
50,670
-2,993
-6% -$108K 0.02% 303
2021
Q3 		$1.99M Sell
53,663
-3,610
-6% -$122K 0.02% 320
2021
Q2 		$2.24M Buy
+57,273
New +$2.21M 0.02% 294

Other funds holding IMCR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

ALPS Advisors's IMCR Position: Q2 2026 in Review

ALPS Advisors increased its Immunocore (IMCR) stake by 25% in Q2 2026, buying an estimated $301K and bringing the position to 51,420 shares worth $1.63M. The position accounts for 0.01% of the portfolio, ranked #583.

ALPS Advisors first reported a position in IMCR in Q2 2021 and has held it in 21 quarters since. The position peaked at $2.28M in Q1 2024. 37 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • ALPS Advisors held 51,420 shares of Immunocore worth $1.63M as of Q2 2026.
  • ALPS Advisors bought 10,159 Immunocore shares in Q2 2026, an estimated $301K.
  • Immunocore made up 0.01% of ALPS Advisors's portfolio in Q2 2026, its #583 holding.
  • ALPS Advisors first reported a position in Immunocore in Q2 2021 and has held it in 21 quarters since.
  • ALPS Advisors's Immunocore position peaked at $2.28M in Q1 2024.
  • 37 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.